T Rowe Price Health Care ETF (TMED)
30.18
-0.17
(-0.56%)
USD |
NASDAQ |
Jan 16, 16:00
30.31
+0.12
(+0.41%)
After-Hours: 20:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.44% | 0.15% | 16.58M | 5225.70 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.91% | -- | 43.75M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund normally invests its net assets in the securities of health care companies. The fund defines health care companies as companies engaged in health care innovations such as developing new and effective therapies: pharmaceuticals and life sciences tools and services. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | T. Rowe Price |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 19, 2026.
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.08% |
| Stock | 99.70% |
| Bond | 0.12% |
| Convertible | 0.00% |
| Preferred | 0.10% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund normally invests its net assets in the securities of health care companies. The fund defines health care companies as companies engaged in health care innovations such as developing new and effective therapies: pharmaceuticals and life sciences tools and services. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | T. Rowe Price |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |